SELLING OFFER
Seek co-innovation with global enterprises and governmental institutions
New arthritis drug using exosomes extracted from stem cells
202 2022. 10. 11.
Summary
This Korean company has the technology to mass-produce exosomes extracted from stem cells. The extracted exosomes can be used as a treatment for arthritis and various intractable diseases. Existing exosomes had the disadvantages of being very expensive and having low purity, but this Korean company has developed low-cost, high-purity exosomes through a mass production system. Now, this Korean company hopes to sign a supply contract with a pharmaceutical and cosmetic company.
Advantages and Innovations
The main effect of mesoderm stem cell exosomes is to improve arthritis and regenerate cartilage.
As such it can produce the effect of weight loss, tissue regeneration, recovery, muscle regeneration, and repair, as well as improving and alleviating stroke symptoms and preventing cardiovascular diseases by protecting the heart.
In addition, they have developed a high-purity, high-concentration exosome by establishing a mass production system that solves the low productivity and low purity that were pointed out as problems with the existing exosome utilization. Through this mass production system, the secretion of exosomes was most effectively produced and the yield was at least 1,000 times higher than that of competitors.
Stage of Development
Description
EX Solution
Cosmetics containing exosome-containing stem cell culture medium
This product has skin regeneration, whitening, and elasticity effects, and has an absolutely high content of exosomes compared to other product
CKCO (Exosome Law Material)
High concentration high purity exosome
Exosomes are used as a treatment for various chronic intractable diseases, and furthermore, it can create new items in the cosmetics industry that requires the regenerative efficacy of stem cell treatment, which is currently rapidly developing, or in various health technology industries related to the improvement of quality of life. In addition, it can be used for vaccine development by applying the properties of exosomes that are effective in the field of anti-tumor.
Technology Keywords
Market Application Keywords
Sector Group
Type and Size of Client
Type and Role of Partner Sought
1) EU technology introduction and export
The world's first exosome-based
- COVID-19 vaccine (CKV2021) in clinical trials at National University Hospital
- Branding by product for treatment of diseases, biomarkers of diseases, and anti-tumor vaccines
- Branding as a high value-added product to the cosmetic industry and the healthcare (atopic treatment) industry that require therapeutic and regenerative efficacy based on the stem cell treatment market
2) International joint R&D
- Write detailed information about international joint R&D (national, target tasks, etc.)
- Task goals and consortium roles, etc.
3) Export of products, etc.
- Discover potential customers by participating in domestic and overseas online and offline (society/exposition)
- Domestic: Korea Stem Cell, Korea Medical Equipment Exhibition, BIOKOREA Biotech, etc.
- Overseas: New York Stem Cell Foundation, International Stem Cell Society ISSCR (Shanghai), etc.
Type of Partnership Considered
Company
Internal Reference
Category
Express your interest in this opportunity.